Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 6,051–6,075 of 7,816 matching trials · page 243 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Digital Reminiscence for People With Dementia NCT03429686 DRT Intervention Runs in: United Kingdom · 1 site |
NA other |
COMPLETED | 60 | University of Nottingham OTHER |
2018-05-02 |
|
Effects of Nucleus Basalis of Meynert Stimulation on Cognitive Disorders in Dementia With Lewy Bodies NCT01340001 Electrical stimulation of the nucleus basalis of Meynert Runs in: France · 1 site |
NA other |
COMPLETED | 6 | University Hospital, Rouen OTHER |
2018-04-30 |
|
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo NCT02192554 Runs in: Bulgaria; Canada; Croatia; France; Germany; Russia; Serbi... · 84 sites |
NA other |
COMPLETED | 450 | Otsuka Pharmaceutical Development & Commercialization, Inc. INDUSTRY |
2018-04-30 |
|
Open Label Study of TRx0014 in Alzheimer's Disease NCT00684944 TRx0014 |
PHASE2 other |
COMPLETED | 111 | TauRx Therapeutics Ltd INDUSTRY |
2018-04-27 |
|
Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment NCT03167840 Physical and Cognitive Training; Physical Training; Cognitive training Runs in: Philippines · 1 site |
NA other |
UNKNOWN | 95 | The Hong Kong Polytechnic University OTHER |
2018-04-27 |
|
Safety and Exploratory Efficacy Study of UCMSCs in Patients With Alzheimer's Disease NCT02672306 UCMSCs; Placebo Runs in: China · 1 site |
PHASE1|PHASE2 other |
UNKNOWN | 16 | South China Research Center for Stem Cell and Regenerative Medicine OTHER |
2018-04-26 |
|
Shanghai Mild Cognitive Impairment Cohort Study NCT01552265 Runs in: China · 1 site |
NA other |
COMPLETED | 400 | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan OTHER |
2018-04-25 |
|
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021 NCT02342548 20 mg BID of PF-02545920 Runs in: Canada; Germany; Poland; United Kingdom; United States · 50 sites |
PHASE2 other |
TERMINATED | 188 | Pfizer INDUSTRY |
2018-04-23 |
|
CCT for Older Diabetic Adults NCT02709629 Individualized and adaptive computerized cognitive training; Active control Runs in: Israel · 1 site |
NA other |
COMPLETED | 85 | Sheba Medical Center OTHER_GOV |
2018-04-19 |
|
ENLIGHTEN: Exercise and NutritionaL Interventions for coGnitive and Cardiovascular HealTh ENhancement NCT01573546 Aerobic Exercise; DASH diet; Health education control Runs in: United States · 1 site |
NA other |
COMPLETED | 160 | Duke University OTHER |
2018-04-18 |
|
Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia NCT01585272 ENA713 Runs in: Taiwan · 4 sites |
PHASE4 symptomatic-cholinergic |
COMPLETED | 121 | Novartis Pharmaceuticals INDUSTRY |
2018-04-18 |
|
Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension NCT02928445 RVT-101 35 mg; RVT-101 70 mg Runs in: Canada; France; Italy; Netherlands; Spain; United Kingdom... · 56 sites |
PHASE2|PHASE3 other |
TERMINATED | 240 | Axovant Sciences Ltd. INDUSTRY |
2018-04-18 |
|
The Role of Aromatherapy With Lavender Oil in the Long-term Care on a Patients Behavioral Problems Associated With Dementia NCT03108781 Lavender Oil; sunflower oil Runs in: Israel · 1 site |
NA other |
UNKNOWN | 60 | Soroka University Medical Center OTHER |
2018-04-18 |
|
Skeletal Muscle as a Mediator of Exercise Induced Effects on Metabolism & Cognitive Function: Role for Myokines & miRNAs NCT02253732 3 months exercise intervention program Runs in: Slovakia · 2 sites |
NA other |
COMPLETED | 30 | Slovak Academy of Sciences OTHER_GOV |
2018-04-17 |
|
Target Hemodynamics and Brain Injury During General Anesthesia in the Elderly NCT02428062 Hemodynamic target; Phenylephrine; Intravenous fluids; Patient's po... Runs in: Italy · 1 site |
PHASE2|PHASE3 other |
SUSPENDED | 1,812 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico OTHER |
2018-04-13 |
|
Adressing PTSD Symptoms and Aggressive Behavior in Vulnerable Children in Burundi NCT03498482 Narrative Exposure Therapy for Forensic Offender Rehabilitation (FORNET) Runs in: Burundi · 1 site |
NA other |
COMPLETED | 19 | University of Konstanz OTHER |
2018-04-13 |
|
IDEA Study Cognitive Stimulation Therapy (CST) Trial in Tanzania NCT02229474 CST Intervention Runs in: Tanzania · 1 site |
NA other |
COMPLETED | 34 | William Keith Gray OTHER |
2018-04-09 |
|
A D1 Agonist For Working Memory NCT02507206 DAR 0-100A; Placebo Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 120 | Antonia New OTHER |
2018-04-09 |
|
Early Markers of Cognitive Change and Alzheimer s Disease NCT01867346 Runs in: United States · 1 site |
NA other |
COMPLETED | 2,850 | National Institute on Aging (NIA) NIH |
2018-04-05 |
|
The Genetic Characterization of Dementia NCT01867359 Runs in: United States · 1 site |
NA other |
COMPLETED | 87 | National Institute on Aging (NIA) NIH |
2018-04-05 |
|
A Combined Training Program for Veterans With Amnestic Mild Cognitive Impairment NCT01962038 Combined Aerobic and Resistance Exercise; Stretching Exercises; Cog... Runs in: United States · 1 site |
NA other |
COMPLETED | 72 | Palo Alto Veterans Institute for Research OTHER |
2018-04-05 |
|
In Vivo Imaging of Therapeutic Electric Current Flow NCT02453763 Transcranial direct current stimulation; MRI Runs in: United States · 1 site |
NA other |
COMPLETED | 17 | University of Florida OTHER |
2018-04-05 |
|
A Mobile Smartphone Application to Promote a Healthy Diet and Physical Activity Among Pregnant Women With GDM - RCT NCT02588729 Pregnant+ app for smartphone Runs in: Norway · 1 site |
NA other |
COMPLETED | 238 | Oslo Metropolitan University OTHER |
2018-04-05 |
|
Positron Emission Tomography (PET) Study in Patients With Alzheimer's Disease NCT03307993 Idalopirdine Runs in: United States · 1 site |
PHASE1 other |
TERMINATED | 3 | H. Lundbeck A/S INDUSTRY |
2018-04-04 |
|
Prevention of Depression in Spouses of People With Cognitive Impairment NCT00321971 PST-MCI/AD Caregiving; NT-MCI/AD Caregiving Runs in: United States · 2 sites |
NA other |
COMPLETED | 73 | University of Pittsburgh OTHER |
2018-04-03 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial